Uptrend Call Working As Progenics Pharmaceuticals Stock Rises 64.8% (PGNX)

SmarTrend identified an Uptrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on November 9th, 2016 at $6.61. In approximately 4 months, Progenics Pharmaceuticals has returned 64.80% as of today's recent price of...